US Patent 10124003 Therapeutic agent for FGFR inhibitor-resistant cancer
Patent 10124003 was granted and assigned to Taiho Pharmaceutical on November, 2018 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10124003 Therapeutic agent for FGFR inhibitor-resistant cancer
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.